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Serotonin (5-HT) is a neuromodulator involved in
regulating mood, appetite, memory, learning, pain,
and establishment of left-right (LR) asymmetry in
embryonic development. To explore the role of 5-
HT in physiology, we have created two forms of
‘‘caged’’ 5-HT, BHQ-O-5HT and BHQ-N-5HT. When
exposed to 365 or 740 nm light, BHQ-O-5HT releases
5-HT through one- or two-photon excitation, respec-
tively. BHQ-O-5HTmediated changes in neural activ-
ity in cultured mouse primary sensory neurons and
the trigeminal ganglion and optic tectum of intact
zebrafish larvae in the form of high-amplitude spiking
in response to light. In Xenopus laevis embryos, light-
activated 5-HT increased the occurrence of LR
patterning defects. Maximal rates of LR defects
were observed when 5-HT was released at stage 5
compared with stage 8. These experiments show
the potential for BHQ-caged serotonins in studying
5-HT-regulated physiological processes.
INTRODUCTION
Serotonin (5-hydroxytyptamine or 5-HT) is an ancient biogenic
amine found in wide variety of eukaryotes, including animals,
plants, fungi, and pathogenic amoebae (Barnes and Sharp,
1999; Feldberg and Toh, 1953; Hoyer et al., 1994; Jackson and
Yakel, 1995; McGowan et al., 1983; Roshchina, 2001). In verte-
brates, 5-HT is a neurotransmitter within both the central and
peripheral nervous systems, and it also acts as a hormone in
diverse tissues (Barnes and Sharp, 1999). In the brain, neurons
in the raphe nuclei region produce 5-HT (Barnes and Sharp,
1999; Frazer and Hensler, 1999). These neurons project into
the cortex and hippocampus and influence an enormous
network of excitatory and inhibitory neurotransmission (Frazer
and Hensler, 1999) involved in regulating mood, appetite, mem-
ory, learning, and other cognitive functions (Barnes and Sharp,
1999; Daubert and Condron, 2010; Feldberg and Toh, 1953;
Kang et al., 2009; McGowan et al., 1983; Rapport et al., 1948).1536 Chemistry & Biology 20, 1536–1546, December 19, 2013 ª2013Serotonin in the CNS and periphery plays a complex role in
mediating pain, both by acting as an algesic by exciting the
peripheral terminations of primary afferent neurons, and in pain
suppression via descending pathways (Bardin, 2011; Basbaum
and Fields, 1978). Interestingly, 5-HT also is involved in em-
bryonic development and the establishment of left-right (LR)
asymmetry (Levin et al., 2006; Vandenberg and Levin, 2010).
This diversity of function implicates 5-HT in several physiological
and pathological processes.
In mammals and other vertebrates, 5-HT function is mediated
by a large number of different receptors. In mammals, there are
14 structurally and pharmacologically distinct 5-HT receptor
subtypes that are grouped into seven major families of 5-HT
receptors, designated 5-HT1–7 (Hoyer et al., 1994). One of these
families, the 5-HT3 receptors, comprises ligand-gated ion chan-
nels that mediate fast synaptic transmission (Barnes and Sharp,
1999) through a transient inward current that rapidly depolarizes
the cell. The remaining six receptor families are members of the
G protein-coupled receptor superfamily and mediate a wide
range of physiological and pharmacological responses (Barnes
and Sharp, 1999). Several classes of antidepressant, antipsy-
chotic, anxiolytic, and antimigraine drugs target these 5-HT
signaling systems (Barnes and Sharp, 1999).
To explore the role of 5-HT in a variety of physiological
contexts, a light-activated form of it would be useful. This can
be achieved by covalently connecting a photoremovable
protecting group (PPG) to 5-HT, thereby blocking or ‘‘caging’’
its action (Ellis-Davies, 2007; Kla´n et al., 2013; Kramer and
Chambers, 2011; Lee et al., 2009; Mayer and Heckel, 2006;
Specht et al., 2009; Young and Deiters, 2007). Exposure to light
releases or ‘‘uncages’’ 5-HT in its active form. Ideally, the caged
5-HT would be highly sensitive to light at wavelengths not
detrimental to biological systems; release 5-HT rapidly; and in
quantitative yield upon light exposure, exhibit no off-target
effects, and be completely stable under physiological conditions
in the dark. In addition, sensitivity to 5-HT release through two-
photon excitation (2PE) is desirable for localization of release
to subcellular levels (Bort et al., 2013; Dore, 2005; Dore and
Wilson, 2011; Warther et al., 2010). Four caged 5-HTs are
known in the literature: 2-((2-(5-hydroxy-1H-indol-3-yl)ethyl)
amino)-2-(2-nitrophenyl)acetic acid (N-CNB-5HT), 2-((3-(2-
aminoethyl)-1H-indol-5-yl)oxy)-2-(2-nitrophenyl)acetic acid (O-
CNB-5HT), 1-(2-nitrophenyl)ethyl (2-(5-hydroxy-1H-indol-3-yl)Elsevier Ltd All rights reserved
Figure 1. Caged Serotonins
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Light-Activated Serotoninethyl)carbamate (NPEC-N-5HT) (Boahen and MacDonald, 2005;
Breitinger et al., 2000), and [Ru(bpy)2(5HT)2]
2+ (Zayat et al., 2006)
(Figure 1). Hess and coworkers synthesized N-CNB-5HT and
O-CNB-5HT to study the kinetics of the 5-HT3 ligand-gated ion
channel (Breitinger et al., 2000). The rate constant for release
of 5-HT from N-CNB-5HT was too slow for that compound to
be useful in the study, but O-CNB-5HT had sufficiently rapid
release kinetics, albeit low photolysis Qu and molar absorptivity.
The preparation and photolysis of 2-(5-(1-(2-nitrophenyl)ethoxy)-
1H-indol-3-yl)ethanamine (NPE-O-5HT) (Boahen and MacDon-
ald, 2005) and [Ru(bpy)2(5HT)2]
2+ (Zayat et al., 2006) were
reported by MacDonald and Etchenique, respectively, and Toc-
ris Bioscience sells NPEC-N-5HT commercially (catalog no.
3991), but the use of these compounds in a study of 5-HT phys-
iology has not yet been reported.
We report the preparation of two (8-bromo-7-hydroxyquino-
lin-2-yl)methyl (BHQ)-protected 5-HT compounds 2-(((3-
(2-aminoethyl)-1H-indol-5-yl)oxy)methyl)-8-bromoquinolin-7-ol
(BHQ-O-5HT) and (8-bromo-7-hydroxyquinolin-2-yl)methyl (2-
(5-hydroxy-1H-indol-3-yl)ethyl)carbamate (BHQ-N-5HT) (Fig-Chemistry & Biology 20, 1536–154ure 1) and their suitability for spatially and temporally control-
ling the release of 5-HT through one-photon excitation (1PE)
and 2PE within a biological system. We found that BHQ-O-
5HT depolarized sensory neurons when photolyzed in culture
and in larval zebrafish (Danio rerio) comparable to that
observed by 5-HT by itself. Light-induced release of 5-HT
from BHQ-O-5HT in stage 5 Xenopus laevis embryos signifi-
cantly increases the rate of LR patterning defects in the
frog. Activation of 5-HT at later stages had a less significant
effect.
RESULTS AND DISCUSSION
We chose 8-bromo-7-hydroxyquinoline (BHQ) as the caging
group for 5-HT because it has good sensitivity to 1PE-mediated
photolysis at biologically compatible wavelengths (>350 nm)
(Fedoryak and Dore, 2002; Zhu et al., 2006) and rapid release
kinetics (Ma et al., 2012). High sensitivity to light is important
for working in thick or pigmented biological tissues, such as
whole larval zebrafish or X. laevis embryos. Rapid release ki-
netics is critical for studying fast signaling events initiated by
neurotransmitters and for taking advantage of BHQ’s sensitivity
to 2PE (Fedoryak and Dore, 2002; Zhu et al., 2006), a sensitivity
that is better than that of many groups currently used in biolog-
ical studies, yet not as sensitive as others (Dore, 2005; Dore and
Wilson, 2011; Kla´n et al., 2013; Warther et al., 2010). To take
advantage of the tight spatial release that 2PE affords, the
release kinetics must be faster than diffusion out of the excitation
volume. BHQ’s moderate sensitivity to 2PE and rapid release ki-
netics could be advantageous for future biological studies.
Typically, phenols and alcohols require a carbonate linker for
efficient release from the caging group after photoexcitation,
but the initially released carbonate must first decarboxylate to
yield the free phenol or alcohol. This slow step of the release
process (t = 240–270 ms for phenols) is not optimal (Zhao
et al., 2006). It would be better to release phenol directly. To
test this, we synthesized 8-bromo-2-(phenoxymethyl)quinolin-
7-ol (BHQ-OPh) from bromo-7-(methoxymethoxy)quinolin-2-yl)
methanol (MOM-BHQ-OH) (Figure 2A). MOM-BHQ-OH, pre-
pared from 8-bromo-7-hydroxyquinaldine as described previ-
ously (Ma et al., 2012), was converted to the corresponding
mesylate that was subsequently displaced by phenol in good
yield to provide the desired phenyl ether. Removal of the
methoxymethyl ether (MOM) protecting group with trifluoroace-
tic acid (TFA) in methanol afforded BHQ-OPh. BHQ-OPh was
reasonably stable under simulated physiological conditions
consisting of 100mMpotassium 3-(N-morpholino)propanesulfo-
nate (KMOPS) buffer at pH 7.2, with a time constant for hydro-
lysis in the dark (tdark) = 95 hr. BHQ-OPh photolyzes with a
quantum efficiency (Qu) = 0.19 at 365 nm and a 2PE photolysis
uncaging action cross-section (du) = 0.56 GM [GM = 10
50
(cm4 s)/photon] at 740 nm in KMOPSbuffer (Figure 2A). Figure S1
(available online) shows the time course of photolysis of BHQ-
OPh by 1PE and 2PE. These results demonstrated that phenols
were sufficiently good leaving groups for light-mediated release
from BHQ and that protection and release of the phenol on 5-HT
(and other neuromodulators) from BHQ were feasible.
We prepared two versions of the photoactivatable 5-HT: BHQ-
O-5HT and BHQ-N-5HT from MOM-BHQ-OH and an6, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1537
Figure 2. Synthesis and Photolysis of BHQ-OPh and Syntheses of
BHQ-O-5HT and BHQ-N-5HT
(A) Preparation and photolysis of BHQ-OPh. (a) Methanesulfonyl chloride
(MsCl), ethyldiisopropylamine (DIEA), THF, RT, 2 hr, 68%. (b) Phenol, 1 M KOH
(aqueous), THF, 72%. (c) TFA, CH3OH. Time courses for the photolysis of
BHQ-OPh are shown in Figure S1.
(B) Preparation of BHQ-O-5HT. (a) MsCl, DIEA, THF, RT, 2 hr, 68%. (b) K2CO3,
CH3CN, reflux, 48 hr, 78%. (c) TFA, CH2Cl2, RT, 1 hr, 57%.
(C) Preparation of BHQ-N-5HT. (a) carbonyldiimidazole, THF, RT, 2 hr, 63%. (b)
DMF, 60C, 12 hr, 65%. (c) TBAF, THF, RT, 15min, 85%. (d) Concentrated HCl
(trace), CH3OH, RT, 12 hr, 55%.
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pounds are distinguished by the type of linkage between the
PPG and 5-HT. The O-version has a phenolic ether linkage,
whereas the N-version uses a carbamate linker. The latter would
place limitations on the use of BHQ-N-5HT that are discussed1538 Chemistry & Biology 20, 1536–1546, December 19, 2013 ª2013below. To synthesize BHQ-O-5HT, MOM-BHQ-OH was con-
verted to the corresponding mesylate and displaced by the
Boc-protected serotonin tert-butyl (2-(5-hydroxy-1H-indol-3-yl)
ethyl)carbamate (N-Boc-5HT) that was prepared as described
previously (Breitinger et al., 2000), to generate the doubly
protected compound tert-butyl (2-(5-((8-bromo-7-(methoxy-
methoxy)quinolin-2-yl)methoxy)-1H-indol-3-yl)ethyl)carbamate
[MOM-BHQ-O-5HT(N-Boc)]. Global deprotection with TFA in di-
chloromethane provided BHQ-O-5HT (Figure 2B).
BHQ-N-5HT was prepared by activating the primary alcohol
with carbonyldiimidazole and then treating the resulting carba-
mate (MOM-BHQ-carbonylimidazole) with triisopropylsilyl
(TIPS)-protected serotonin 2-(5-((triisopropylsilyl)oxy)-1H-indol-
3-yl)ethanamine [5HT(O-TIPS)] that was prepared as described
previously (Ho et al., 2003). Removal of first the TIPS protecting
group with tetra-n-butylammonium fluoride (TBAF) was followed
by the MOM deprotection in acidic methanol to provide BHQ-N-
5HT (Figure 2C).
Selected photophysical and photochemical properties of the
two forms of caged 5-HTwere examined (Table 1) and compared
with previously reported caged 5-HTs (Boahen and MacDonald,
2005; Breitinger et al., 2000; Zayat et al., 2006). In contrast to the
CNB- and NPE-protected 5-HTs, the BHQ-protected 5-HTs
have absorbance maxima (lmax) above 350 nm and larger molar
absorptivities (ε), but not as high as [Ru(bpy)2(5HT)2]
2+ that is
more absorbent in the visible region (Table 1). BHQ-O-5HT and
BHQ-N-5HT were each photolyzed under simulated physiolog-
ical conditions (KMOPS buffer [pH 7.2]) with 370 nm light from
amercury lamp (1PE) and 740 nm light from a pulsed Ti:sapphire
laser (2PE) (Chameleon Ultra II, Coherent) (Figure 3). The time
course of the reaction wasmonitored by high-performance liquid
chromatography (HPLC), measuring the disappearance of the
caged compound and appearance of 5-HT (Figure 4). From
these data, the 1-photon quantum efficiencies of photolysis
(Qu) and the 2PE photolysis action cross-sections (du) were
calculated using previously described methods (Davis et al.,
2009; Fedoryak and Dore, 2002; Furuta et al., 1999; Lu et al.,
2003; Zhu et al., 2006). Compared with the CNB- and NPE-pro-
tected 5-HTs and [Ru(bpy)2(5HT)2]
2+, both BHQ-caged 5-HTs
demonstrated superior Qu and sensitivity to light (Qu 3 ε) at
biologically compatible wavelengths. The sensitivity of the
NPE-protected 5-HTs was not explicitly reported (Boahen and
MacDonald, 2005), but the sensitivity of a related compound,
NPE-protected phenylephrine, is 682 at 272 nm (Walker et al.,
1993), a shorter wavelength not well suited for biological exper-
iments. The absorbance spectrum of NPE-caged ATP drops
precipitously as the wavelength increases (Kaplan et al., 1978),
indicating that NPE-protected 5-HTs also have low sensitivity
at l > 300 nm. BHQ-O-5HT was found to be the most sensitive
of all seven caged 5-HTs at 368 nm. Both BHQ-protected 5-
HTs were stable in the dark in buffered aqueous media. The du
values were not reported for the CNB-, NPE-, and Ru(bpy)2-pro-
tected 5-HTs, but the CNB and NPE groups are not considered
sensitive to 2PE (du % 0.04 GM) (Dore, 2005; Dore and Wilson,
2011; Kiskin et al., 2002; Warther et al., 2010), and other conju-
gates of Ru(bpy)2 are only slightly more sensitive (du = 0.01–
0.14 GM) (Nikolenko et al., 2005; Salierno et al., 2010). The du
values of BHQ-O-5HT and BHQ-N-5HT were at least an order
of magnitude larger than CNB- and NPE-protected 5-HT atElsevier Ltd All rights reserved
Table 1. Selected Photophysical and Photochemical Properties of Caged 5-HTs
Caged 5-HT lmax (nm) ε (M
1 cm1) Qu Sensitivity (Qu 3 ε) du (GM) tdark (hr)
O-CNB-5HT 280 800 at 337 nm 0.03 24 NR NR
[Ru(bpy)2(5HT)2]
2+ 488 9,880 0.023 227 NR NR
BHQ-OPh 369 3,200 0.19 608 0.56 95
BHQ-O-5HT 368 2,000 0.30 600 0.50 260
BHQ-N-5HT 370 2,100 0.10 210 0.42 300
UV-vis spectra (Figure S3) and photolysis data on BHQ-OPh (Figure S1), BHQ-O-5HT, and BHQ-N-5HT were acquired in KMOPS buffer at pH 7.2.
Absolute values of du are estimated to be accurate within a factor of two (Furuta et al., 1999), but the relative magnitudes of the values are consistent
when measured on the same apparatus as is the case here. Data for N-CNB-5HT, NPE-O-5HT, and NPEC-N-5HT are not reported. Data for O-CNB-
5HT and [Ru(bpy)2(5HT)2]
2+ are from Breitinger et al. (2000) and Zayat et al. (2006), respectively. NR, not reported.
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The time course for 2PE is in minutes because the excitation
volume is smaller than the sample size, andmore time is required
for a sufficient amount of starting material to be photolyzed to
detectable levels.
BHQ-N-5HT might be less useful in applications using 2PE or
activating the ionotrophic 5-HT receptors, because release of 5-
HT fromBHQ-N-5HT upon light exposure is slow. Initially formed
carbamic acid intermediates typically decompose to CO2 and
the amine on a 6–7 ms timescale (Papageorgiou and Corrie,
1997), a timescale that is slower than the diffusional escape
time from the focal volume of 2PE excitation (estimated at
113–900 ms; Kiskin and Ogden, 2002) and the opening of iono-
trophic 5-HT-gated ion channels (5-HT3 receptors open on the
order of 1–2 ms timescales and remain open for up to 10 ms;
Jackson and Yakel, 1995). Time-resolved studies on BHQ-
caged acetate (Ma et al., 2012) suggest that BHQ-O-5HT re-
leases 5-HT on nanosecond timescales—orders of magnitude
shorter than diffusional timescales.
To test the biological effects of BHQ-O-5HT on neural activity,
extracellular recordings were obtained from dissociated sensory
neurons prepared from mouse dorsal root ganglia (DRGs) and
the trigeminal ganglion or optic tectum in intact zebrafish larva
during exposure to 5-HT, BHQ-O-5HT, or 8-bromo-2-(hydroxy-
methyl)quinolin-7-ol (BHQ-OH). Previous studies have shown
that 5-HT elicits depolarizing responses in small-diameter tri-
geminal ganglion neurons in mammals and type A and C primary
afferent neurons in the DRGs of mammals and frogs (Holz and
Anderson, 1984; Holz et al., 1985; Todorovic and Anderson,
1990; Tsutsui et al., 2008). 5-HT is also known to increase a
hyperpolarization-activated cation current in type Aa and Ab
DRG neurons (Cardenas et al., 1999; Harper and Lawson,
1985a, 1985b; Scroggs et al., 1994; Villie`re and McLachlan,
1996). Figure 5 depicts the results for DRG neurons. For these
experiments, recordings were obtained from DRG neurons
with soma 19 ± 2 mm in diameter (Figure 5A) that are largely noci-
ceptive afferent (C and Ad) neurons, but they can include Aa/Ab
neurons (Harper and Lawson, 1985a, 1985b; Lawson and Wad-
dell, 1991). Therefore, neurons were first tested for a response to
100 mM 5-HT, and then the same neurons were exposed to
500 mM BHQ-O-5HT or BHQ-OH (Figure 3), a control to test for
the effects of the caging group. All compounds were adminis-
tered by pressure ejection of 1 nl of solution from amicropipette,
the tip of which was located 90–110 mm from the neuron cell
body to minimize potential artifacts associated with the pressureChemistry & Biology 20, 1536–154ejection. Cells were exposed to a 1 ms pulse of 365 nm light 10 s
after application of the compound. In all cases, pressure ejection
of BHQ-O-5HT induced small changes in baseline activity DRG
neurons that were likely due to small amounts of uncaged 5-
HT in the solution; however, activity comparable to uncaged 5-
HT was observed only after exposure to a 1 ms pulse of
365 nm light (compare Figure 5B to Figure 5C). For DRG neurons
of this size class, application of 5-HT resulted in a negative
extracellular potential (i.e., depolarization) in 26/34 neurons
tested and a positive potential (i.e., hyperpolarization-activated
cation current) in 8/34 neurons tested. In 17 cases, where there
were multiple cells in the field, biphasic responses were re-
corded. 5-HT and uncaged BHQ-O-5HT elicited the same effect
for any given neuron. Application of the caged compound and
uncaging could be performed repeatedly on the same neuron
under perfusion conditions. No significant change in neuronal
activity was observed after ejection of solvent (Ringer’s solution
with 1% DMSO) or BHQ-OH, or upon exposure to 1PE in the
absence of BHQ-O-5HT (Figure 5B and data not shown).
Together, these results demonstrated that BHQ-O-5HT could
be used to modulate the activity of mammalian neurons in
culture. A cell viability assay (Freshney, 1987) showed no statis-
tical difference (t test, p < 0.01) in the percentage of dying cells
between BHQ-O-5HT-treated and untreated control cultures,
suggesting that mammalian neurons in culture tolerate BHQ-
O-5HT well.
Figure 6 depicts the results of using BHQ-O-5HT to control
neural activity in vivo. For these experiments, zebrafish larvae
were immobilized in agar at 5 days postfertilization (dpf), and
solutions containing 5-HT (100 mM), BHQ-O-5HT (1 mM), or
BHQ-OH (1 mM) dissolved in Ringer’s solution containing 1%
DMSO were microinjected in the vicinity of the maxillary nerve
(Figure 6A). Electrical activity was monitored with a field elec-
trode placed under visual guidance on the ventral aspect of
the trigeminal ganglion (Figure 6A). This placement also likely
detects electrical activity from the anterodorsal lateral line
ganglion (Raible and Kruse, 2000). Whereas injection of 5-HT
typically induced a characteristic change in the electrographic
activity (n = 6/7), injection of BHQ-O-5HT did not significantly
affect baseline activity until after photolysis using 365 nm light
(n = 6/6). In some experiments, a short-lived electrographic
response was observed immediately after injection of BHQ-O-
5HT but before exposure to light, suggesting that a small amount
of 5-HT was released during handling or injection; however, in
these cases, exposure to light also resulted in a significant6, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1539
Figure 3. Photolysis Reaction of BHQ-O-5HT and BHQ-N-5HT
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compound had remained in a caged state. In these experiments,
repeated exposure to light resulted in repeated induction of
neural activity (Figure 6C) for up to ten trials; however, as
expected, the amount of activity began to diminish with time
and the number of exposures to light. This suggests that enough
caged compound remained after illumination to permit repeated
stimulation experiments in intact preparations. No change in
baseline activity was observed after injection with BHQ-OH or
by exposing the larva to flashes of light in the absence of
BHQ-O-5HT. Comparable results were obtained for experiments
directed toward the optic tectum (Figure S2). We observed no
mortality resulting from injection or an obvious increase in cell
death in the vicinity of the injection site (n = 47) during the course
of the experiments, indicating that the zebrafish tolerate BHQ-O-
5HT.
Because 5-HT signaling is required for LR patterning in X.
laevis embryos (Fukumoto et al., 2005a, 2005b; Vandenberg
et al., 2013), we used this endpoint and animal model to assay
the physiological action of caged 5-HT molecules. To test the
effects of BHQ-O-5HT on LR patterning, embryos were soaked
in BHQ-O-5HT (1 mM) from the one-cell through 32-cell stage
(stage 5), washed, and then both the top and bottom of the
embryos were exposed to light for 1 hr using a broad-spectrum
lamp to uncage 5-HT. LR patterning was assessed at stage 45
via inspection of three asymmetric organs: the heart, stomach,
and gall bladder (Figure 7A). In contrast to embryos soaked
in 5-HT, no LR patterning defects were observed, indicating
that BHQ-O-5HT does not penetrate the cell membrane of
the Xenopus embryo and is not taken up via the serotonin
transporter (Figure 7B). Additional embryos were injected with
BHQ-O-5HT at the one-cell stage, and 5-HT was uncaged
starting at the 16-cell stage using the broad-spectrum lamp.
LR defects including situs inversus and heterotaxia were
observed in BHQ-O-5HT-injected embryos after uncaging
with a similar percentage of affected embryos as those
observed when 5-HT is injected (Figure 7C). A low rate of LR
defects was also observed in embryos injected with BHQ-O-
5HT that were maintained in the dark throughout the ex-
periment, suggesting that a small amount of 5-HT is released
during handling, injection, or incubation. To verify temporal
control of BHQ-O-5HT uncaging, embryos were injected at
the one-cell stage and then maintained in the dark until two
later stages of development: 32-cell stage (stage 5) and early
blastula (stage 8). Significant increases in LR patterning defects1540 Chemistry & Biology 20, 1536–1546, December 19, 2013 ª2013were observed only when uncaging occurred at stage 5
(Figure 7D).
Under all conditions, BHQ-O-5HT produced very low levels of
toxicity, including few dead or deformed embryos or tadpoles. In
experiments where embryos were soaked in BHQ-O-5HT,
toxicity rates were 5%–6% either when maintained in the dark
or uncaged, rates that were similar to the rates observed in
untreated controls (7%, p > 0.05). Likewise, when BHQ-O-5HT
was injected, low toxicity (4%–12%) was observed whether
maintained in the dark or uncaged, similarly to rates observed
in controls (5%–7%, p > 0.05). Injections with BHQ-OH
produced few LR patterning defects (2%–3%, see Figure 7D)
and little toxicity (4%–6% compared with 5% in untreated
controls, p > 0.05). Soaking and injection experiments were
also conducted with BHQ-N-5HT, but uncaging this molecule
did not disrupt LR patterning in any experiment, regardless of
which treatment route was used (data not shown). This might
be due to the inability of light to penetrate the pigment in early
cleavage stage embryos with enough intensity to release 5-HT
from BHQ-N-5HT.
SIGNIFICANCE
Based on the ability of the BHQ protecting group to photo-
chemically release phenol through both 1PE and 2PE, the
two forms of caged 5-HT prepared, BHQ-O-5HT and BHQ-
N-5HT, have higher Qu and du values than previously
reported caged 5-HTs. BHQ-O-5HT was found to be more
sensitive to light at 368 and 740 nm than BHQ-N-5HT, and
based on the behavior of similar compounds (Ma et al.,
2012), its release kinetics is expected to be faster than diffu-
sion rates and the opening of 5-HT3 receptors. BHQ-O-5HT
mediated the light activation of 5-HT, subsequently depola-
rizing mammalian neurons in culture or in the nervous
system of intact larval zebrafish (5–7 dpf). In the developing
Xenopus embryo, light-induced release of 5-HT disrupted
LR patterning maximally at stage 5 of development.
Taken together, these experiments demonstrate the
potential of BHQ-caged 5-HT to enable the advanced study
of 5-HT’s physiological role in a variety of biological con-
texts, whole animal studies in particular. For example,
BHQ-caged 5-HT could enable the exploration of mecha-
nisms involved in the propagation of coherent neural activity
(i.e., seizures) in the brain, potentially impacting our under-
standing of epilepsy and other seizure disorders. MoreElsevier Ltd All rights reserved
Figure 4. Time Course for Photolysis of
BHQ-O-5HT and BHQ-N-5HT
Time course for photolysis of BHQ-O-5HT (closed
circles) and BHQ-N-5HT (closed squares) at (A)
365 nm (1PE) and (B) 740 nm (2 PE) in KMOPS
buffer (pH 7.2) and the rise of 5-HT from BHQ-O-
5HT (open circles) and BHQ-N-5HT (open
squares), respectively. The concentration was
determined by HPLC using an external standard
and is the average of at least three runs. Lines are
least-squares fits of a single exponential decay or
a single exponential rise to max. From the decay
curves, Qu and du were calculated. Error bars
represent the SD of the measurement.
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of 5-HT in modulating mood, appetite, memory, learning,
and other cognitive functions. In addition, 5-HT has been
shown to play important roles in early developmental
patterning events outside of neural tissue, such as LR
patterning and melanocyte differentiation. Thus, BHQ-
caged 5-HT, which can be manipulated both spatially and
temporally, provides significant experimental power to
dissect and understand themechanisms behind 5-HT-medi-
ated signaling in the developing embryo. The BHQ-caged
serotonins are relatively nontoxic, have relatively little
leakage, and can be released using standard laboratory
equipment, enabling biologists to better probe the role of
5-HT signaling pathways in the brain and in early develop-
mental processes.
EXPERIMENTAL PROCEDURES
Preparation of BHQ-OPh
(8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl
Methanesulfonate
To prepare (8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl methanesulfo-
nate (MOM-BHQ-OMs), MOM-BHQ-OH (0.526 g, 1.76 mmol) was dissolved in
tetrahydrofuran (THF). Ethyldiisopropylamine (0.61 ml, 3.52 mmol) and meth-
anesulfonyl chloride (0.20 ml, 2.64 mmol) were successively added dropwise,
followed by stirring at room temperature (RT) for 2 hr. The reaction was
concentrated, and the residue was purified over silica gel with a gradient
from 100% hexanes to 2:3 ethyl acetate (EtOAc)/hexanes, collecting the prod-
uct as a white solid (0.446 g, 68%): 1H nuclear magnetic resonance (1H NMR)
(400 MHz, CDCl3) d 8.19 (d, 1H), 7.79 (d, 1H), 7.55 (d, 1H), 7.52 (d, 1H), 5.57 (s,
2H), 5.43 (s, 2H), 3.58 (s, 3H), 3.23 (s, 3H); 13C NMR (101 MHz, CDCl3) d 155.8,
155.7, 146.1, 137.9, 128.2, 124.9, 118.7, 118.0, 112.5, 95.6, 72.4, 56.9, 38.7;
high-resolution mass spectrometry-electrospray ionization (HRMS-ESI) (m/z)
calcd for [M+H]+ 375.9849, 377.9828; found 375.9846, 377.9825.
8-bromo-7-(methoxymethoxy)-2-(phenoxymethyl)quinoline
To prepare 8-bromo-7-(methoxymethoxy)-2-(phenoxymethyl)quinoline
(MOM-BHQ-OPh), MOM-BHQ-OMs (0.035 g, 0.093 mmol) was dissolved in
THF (2ml). Phenol (0.016 g, 0.17mmol) was added, followed by 1M potassium
hydroxide solution (170 ml), and the reaction was stirred at RT for 12 hr. The sol-
vent was removed on a rotary evaporator, and the remaining residuewas taken
up in EtOAc that was washed successively with water and brine. The EtOAc
was removed on a rotary evaporator, and the remaining residue was purified
by column chromatography with 9:1 hexanes/EtOAc. Fractions were collected
and concentrated to yield a residue on the flask wall (0.025 g, 0.067 mmol,
72%): 1H NMR (400 MHz, CDCl3) d 8.13 (d, J = 8.2 Hz, 1H), 7.75 (d, J =
9.0 Hz, 1H), 7.65 (d, J = 8.2 Hz, 1H), 7.50 (d, J = 9.0 Hz, 1H), 7.30 (m, 2H),
7.05 (d, J = 7.8 Hz, 2H), 6.97 (t, J = 7.4 Hz, 1H), 5.46 (s, 2H), 5.42 (s, 2H),
3.59 (s, 3H); 13C NMR (101 MHz, CDCl3) d 160.0, 158.6, 155.4, 146.0, 137.3,Chemistry & Biology 20, 1536–154129.8, 128.2, 124.7, 121.4, 118.3, 117.4, 115.110,112.3, 95.6, 71.4, 56.9;
HRMS-ESI (m/z) calcd for [M+H]+ 374.0386, 376.0366; found 374.0401,
376.0382.
BHQ-OPh
MOM-BHQ-OPh (0.025 g, 0.067 mmol) was dissolved in CH3OH (1 ml). TFA
(0.5 ml) was added, and the reaction was stirred for 30 min. The solvent was
evaporated, and the remaining residue was taken up in EtOAc, washed
successively with water and brine, and concentrated. The remaining residue
was purified by column chromatography with 8:2 hexanes/EtOAc. Fractions
were collected and concentrated to yield a residue on the flask wall: 1H
NMR (400 MHz, CDCl3) d 8.11 (d, J = 8.6 Hz, 1H), 7.71 (d, J = 8.6 Hz, 1H),
7.61 (d, J = 8.6 Hz, 1H), 7.31 (m, 3H), 7.04 (d, J = 7.8 Hz, 2H), 6.98 (t, J =
7.4 Hz, 1H), 5.35 (s, 2H); 13C NMR (101 MHz, CDCl3) d 159.8, 158.6, 154.4,
145.5, 137.4, 129.8, 128.6, 123.9, 121.4, 117.9, 117.7, 115.1, 108.0, 71.3;
HRMS-ESI (m/z) calcd for [M+H]+ 330.0124, 332.0104; found 330.0136,
332.0123.Preparation of BHQ-N-5HT
(8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl 1H-imidazole-1-
carboxylate
To prepare (8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl 1H-imidazole-
1-carboxylate (MOM-BHQ-carbonylimidazole), MOM-BHQ-OH (0.100 g,
0.34 mmol) was dissolved in THF. Carbonyldiimidazole (0.082 g, 0.50 mmol)
was added, and the reaction stirred at RT for 2 hr. The reaction was concen-
trated, and the residue was dissolved in EtOAc, washed successively with
water and brine, dried over MgSO4, filtered, and concentrated in vacuo. The
crude product was purified by column chromatography with silica gel, eluting
with a gradient from 1:1 EtOAc/hexanes to 100% EtOAc, yielding a white solid
(0.084 g, 63%): 1H NMR (400 MHz, CDCl3) d 8.28 (s, 1H), 8.14 (d, J = 8.4 Hz,
1H), 7.74 (d, J = 9.0 Hz, 1H), 7.55 (s, 1H), 7.50 (d, J = 9.0 Hz, 1H), 7.39
(d, J = 8.4 Hz, 1H), 7.11 (s, 1H), 5.75 (s, 2H), 5.39 (s, 2H), 3.56 (s, 3H); 13C
NMR (101 MHz, CDCl3) d 155.8, 155.4, 148.9, 146.1, 137.6, 137.6, 131.0,
128.0, 124.7, 118.0, 117.7, 117.6, 112.6, 95.6, 69.9, 56.8; HRMS-ESI (m/z)
calcd for [M+H]+ 392.0246, 394.0225; found 392.0262, 394.0244.
(8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl (2-(5-
((triisopropylsilyl)oxy)-1H-indol-3-yl)ethyl)carbamate
To prepare (8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl (2-(5-((triiso-
propylsilyl)oxy)-1H-indol-3-yl)ethyl)carbamate [MOM-BHQ-N-5HT(O-TIPS)],
5HT(O-TIPS) (0.067 g, 0.020 mmol) was dissolved in a small amount ofN,N-di-
methylformamide (DMF). MOM-BHQ-carbonylimidazole (0.100 g, 0.25 mmol)
was added, and the reaction was heated to 60C and stirred overnight. The
solvent was removed in vacuo, and the residue was partitioned between
EtOAc and water. The EtOAc layer was dried over MgSO4, filtered, and
concentrated in vacuo. The crude product was purified by column chromatog-
raphy with silica gel, eluting with a gradient from 100% hexanes to 1:1 EtOAc/
hexanes, yielding the product as a solid (0.0859 g, 65%): 1H NMR (400 MHz,
CDCl3) d 8.07 (d, J = 8.4 Hz, 1H), 7.95 (s, 1H), 7.72 (d, J = 9.0 Hz, 1H), 7.48
(d, J = 9.0 Hz, 1H), 7.36 (d, J = 8.4 Hz, 1H), 7.18 (d, J = 8.7 Hz, 1H), 7.04 (s,
1H), 7.00 (s, 1H), 6.81 (d, J = 8.7 Hz, 1H), 5.44 (s, 2H), 5.40 (s, 2H), 5.02
(br, 1H), 3.58 (t, J = 6.6 Hz, 2H), 3.57 (s, 3H), 2.95 (t, J = 6.6 Hz, 2H), 1.266, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1541
Figure 5. BHQ-O-5HT Acts on Mouse DRG
Neurons in Culture
(A) Brightfield image of mouse DRG neurons in
culture showing placement of the field recording
pipette (black arrowhead) and direction toward the
microinjection pipette (open white arrowhead) that
was located 100 mm from the cells and is out of the
field of view.
(B) Pressure injection of 1 nl of a 100 mM buffered
5-HT solution induced activity in the medium-
sized DRG neuron shown in (A), but no change in
activity was observed upon exposure to a 1 ms
pulse of 365 nm light (1PE).
(C) Although pressure ejection of a 1 mM buffered
BHQ-O-5HT solution induced a small change
baseline activity in the same neuron as (B), a sig-
nificant change in activity was observed after
exposure to a 1 ms pulse of 365 nm light. The
traces comparing 5-HT to BHQ-O-5HT are
temporally aligned to facilitate comparison.
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Light-Activated Serotonin(m, J = 7.3 Hz, 3H), 1.11 (d, J = 7.3 Hz, 18H); 13C NMR (126 MHz, CDCl3)
d 158.8, 156.2, 155.2, 149.7, 145.8, 137.0, 131.8, 127.9, 127.8, 124.4, 122.9,
118.1, 117.2, 116.3, 112.3, 111.4, 107.8, 95.4, 77.2, 67.5, 56.6, 41.2, 25.7,
18.1, 12.7; HRMS-ESI (m/z) calcd for [M+H]+ 656.2155, 658.2135; found
656.2171, 658.2154.
(8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl (2-(5-hydroxy-
1H-indol-3-yl)ethyl)carbamate
To prepare (8-bromo-7-(methoxymethoxy)quinolin-2-yl)methyl (2-(5-hydroxy-
1H-indol-3-yl)ethyl)carbamate (MOM-BHQ-N-5HT), MOM-BHQ-N-5HT(O-
TIPS) (85.9 mg, 0.13 mmol) was dissolved in a small amount of THF. TBAF
(0.2 ml, 1.0 M in THF) was added slowly, and the reaction stirred at RT for
15 min. The reaction was concentrated, and the residue was partitioned be-
tween EtOAc and water. The organic layer was washed with water and brine,
dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude
product was purified by column chromatography with silica gel, eluting with
a gradient from 100% hexanes to 1:1 EtOAc/hexanes, yielding the product
as a solid (55 mg, 85%): 1H NMR (400 MHz, CDCl3) d 8.06 (s, 1H), 8.02 (d,
J = 8.3 Hz, 1H), 7.97 (d, J = 9.1 Hz, 1H), 7.67 (d, J = 9.0 Hz, 1H), 7.45 (d, J =
9.1 Hz, 1H), 7.31 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 8.6 Hz, 1H), 6.96 (d, J =
13.2 Hz, 1H), 6.74 (dd, J = 9.1, 14.4 Hz, 1H), 5.41 (s, 2H), 5.38 (s, 2H), 5.18
(br, 1H), 3.56 (s, 3H), 3.48 (q, J = 6.6 Hz, 2H), 2.92 (d, J = 26.8 Hz, 1H), 2.84
(t, J = 6.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) d 158.8, 156.7, 155.5, 149.8,
145.9, 137.4, 131.8, 128.1,126.2, 124.6, 123.4, 118.3, 117.5, 115.8, 112.3,
112.1, 103.2, 103.3, 95.6, 67.7, 56.9, 41.6, 26.0; HRMS-ESI (m/z) calcd for
[M+H]+ 500.0821, 502.0801; found 500.0823, 502.0810.
BHQ-N-5HT
MOM-BHQ-N-5HT (45 mg, 0.090 mmol) was dissolved in CH3OH. A small
amount of concentrated HCl was added, and the reaction was stirred over-
night. The reaction was diluted with EtOAc and washed successively with
saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and
concentrated in vacuo. The crude product was purified by HPLC with 50%
CH3CN/50% H2O (with 0.1% TFA) and the first peak (retention time 4.5 min)
was collected and concentrated (22.5 mg, 55%): 1H NMR [500 MHz,
(CD3)2CO] d 9.63 (br, 1H), 8.11 (d, J = 8.3 Hz, 1H), 7.68 (d, J = 8.8 Hz, 1H),
7.26 (t, J = 8.3 Hz, 2H), 7.23 (d, J = 8.8 Hz, 1H), 7.07 (d, J = 8.6 Hz, 1H), 6.98
(s, 1H), 6.88 (s, 1H), 6.57 (d, J = 8.6 Hz, 1H), 6.48 (br, 1H), 5.22 (s, 2H), 3.34
(t, J = 7.3 Hz, 2H), 2.79 (t, J = 7.3 Hz, 2H); 13C NMR (101 MHz, (CD3)2CO)
d 159.1, 156.2, 155.8, 150.7, 145.9, 137.1, 131.6, 128.5, 128.1, 127.6, 123.2,
118.6, 116.8, 111.6, 111.5, 106.9, 102.6, 66.8, 41.6, 29.7, 25.9; HRMS-ESI
(m/z) calcd for [M+H]+ 456.0559, 458.0538; found 456.0574, 458.0567.
Preparation of BHQ-O-5HT
MOM-BHQ-O-5HT(N-Boc)
N-Boc-5HT (97 mg, 0.35 mmol) was dissolved in CH3CN, and potassium
carbonate (86 mg, 0.62 mmol) was added. MOM-BHQ-OMs (188 mg,
0.50 mmol) was added in one portion, and the reaction was stirred at reflux
for 2 days. The reaction was allowed to cool and then filtered and concen-1542 Chemistry & Biology 20, 1536–1546, December 19, 2013 ª2013trated. The residue was purified by column chromatography with silica gel,
eluting with a gradient from 100% hexanes to 3:1 EtOAc/hexanes, yielding a
yellow oil (151 mg, 78%): 1H NMR (400 MHz, CDCl3) d 8.14 (d, J = 8.4 Hz,
1H), 7.97 (s, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.50 (d,
J = 9.0 Hz, 1H), 7.23 (s, 1H), 7.02 (m, 2H), 5.50 (s, 2H), 5.42 (s, 2H), 3.59 (s,
3H), 3.42 (t, J = 6.5 Hz, 2H), 2.90 (t, J = 6.5 Hz, 2H), 1.43 (s, 9H); 13C NMR
(101 MHz, CDCl3) d 170.7, 161.2, 161.1, 160.6, 156.1, 155.3, 153.0, 146.0,
137.2, 131.9, 128.2, 124.7, 118.5, 117.3, 112.8, 112.1, 103.5, 102.6, 95.6,
77.4, 72.2, 56.9, 40.8, 28.7, 26.0; HRMS-ESI (m/z) calcd for [M+H]+
556.1447, 558.1427; found 556.1432, 558.1420.
BHQ-O-5HT
MOM-BHQ-O-5HT(N-Boc) (0.047 g, 0.085mmol) was dissolved in CH2Cl2. Tri-
fluoroacetic acid was added, and the reaction stirred at RT for 1 hr. The solvent
was removed in vacuo, and the residue was purified by HPLC with 50%
CH3CN/50% H2O (with 0.1% TFA). Fractions containing only one peak were
combined and concentrated (0.020 g, 57%): 1H NMR (600 MHz, CD3OD)
d 8.29 (d, J = 8.4 Hz, 1H), 7.80 (d, J = 8.8 Hz, 1H), 7.67 (d, J = 8.3 Hz, 1H),
7.31 (d, J = 7.6 Hz, 1H), 7.30 (d, J = 8.8 Hz, 1H), 7.24 (d, J = 2.1 Hz, 1H),
7.15 (s, 1H), 6.98 (dd, J = 8.8, 2.2 Hz, 1H), 5.46 (s, 2H), 3.20 (m, 2H), 3.06 (t,
J = 7.3 Hz, 2H); 13C NMR (150 MHz, CD3OD) d 162.2, 161.8, 151.6, 147.5,
138.9, 133.3, 131.5, 129.0, 125.3, 125.2, 122.2, 117.6, 113.1, 112.9, 109.6,
103.3, 98.9, 61.6, 41.2, 24.7; HRMS-ESI (m/z) calcd for [M+H]+ 412.0661,
414.0640; found 412.0651, 414.0626.
1HNMR spectra for all compounds and anHPLC chromatogram for BHQ-O-
5HT demonstrating purity are provided in the Supplemental Information.
Photochemistry
Determination of ε
A weighed portion of BHQ-O-5HT was dissolved in CH3OH. A measured
aliquot of this solution was withdrawn and placed in KMOPS buffer (3.0 ml)
and mixed thoroughly to generate a 100 mM solution of BHQ-O-5HT. The
absorbance (A) of this solution at lmax = 368 nm was measured. This method
was repeated twice with different masses of BHQ-O-5HT. The three absor-
bance values obtained were averaged, and the molar extinction coefficient
(ε) value at lmax = 368 nm was calculated to be 2,000 M
1 cm1 using the
equation A = εlc, where A is the absorbance, l is the path length of the cuvette,
and c is the concentration of the solution. The ε value of BHQ-OPh and BHQ-
N-5HT was measured similarly. See Figure S3 for representative UV-visible
(vis) spectra of BHQ-OPh, BHQ-N-5HT, and BHQ-O-5HT.
Determination of tdark
Three 100 mM solutions of BHQ-O-5HT in KMOPS were created and stored in
the dark. Aliquots (20 ml) were removed periodically from each solution and
analyzed by HPLC. The concentration of BHQ-O-5HT (measured by external
standard) for each time point for each solution was averaged and plotted
versus time. A simple single exponential decay curve provided the best fit
and was used to determine the tdark value. The tdark value of BHQ-OPh and
BHQ-N-5HT was measured similarly.Elsevier Ltd All rights reserved
Figure 6. BHQ-O-5HT Excites Trigeminal Neurons in Intact Zebrafish Larva
(A) Lateral brightfield view of a zebrafish larva at 5 dpf showing placements of the field recording (black arrowhead) and microinjection (open white arrowhead)
pipettes relative to the trigeminal ganglion (gV). Dorsal is up and anterior is left, with the eye, hindbrain and ear (Oto, otocyst) indicated for reference. The inset is a
confocal fluorescence image of the trigeminal ganglion obtained from a comparable experiment using a 5 dpf larva expressing the cameleon calcium indicator in
all neurons. Placements of the recording (arrowhead) and injection (open arrowhead) pipettes are indicated.
(B and C) In vivo extracellular field recordings of 5-HT-induced changes in trigeminal ganglion activity. (B) Baseline recordings from the ventral aspect of the
trigeminal ganglion show low-amplitude neural activity. Microinjection (inj.) of 0.5 nl of a 1 mM buffered 5-HT solution in the region of the putative maxillary nerve
elicited a brief bust of high-amplitude spiking; in some cases, this initial discharge was followed by a second burst within a few seconds of the injection. Bars
above traces denote significant changes from baseline activity. No change in activity was observed upon exposure to three 1 ms pulses of 365 nm light (1PE)
spaced15 s apart. Electronic spikes associatedwith the lamp discharge are denoted with asterisks; these occur about 60%of the time. (C) Microinjection of 1 nl
of a 500 mM buffered BHQ-O-5HT solution did not alter baseline activity. Photolysis of BHQ-O-5HT by exposure to 1 ms pulses of 365 nm light elicited high-
amplitude spiking that typically lasted a few seconds (bars). The traces comparing 5-HT to BHQ-O-5HT are temporally aligned to facilitate comparison. A similar
experiment was carried out in the optic tectum of 7 dpf zebrafish larva (Figure S2).
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Light-Activated SerotoninDetermination of the Uncaging Qu
As described previously (Adams et al., 1988; Davis et al., 2009; Fedoryak and
Dore, 2002; Furuta et al., 1999; Lu et al., 2003; Zhu et al., 2006), the Qu value
was calculated using the equation Qu = (Ist90%)
1, where I is the irradiation
intensity in einstein$cm2$s1, s is the decadic extinction coefficient (1,000
times ε), and t90% is the time in seconds required for the conversion of 90%
of the starting material to product. To find t90%, a solution of BHQ-O-5HT in
KMOPSwas prepared and placed in a cuvette along with a small stir bar. While
stirring, the solution was irradiated with UV light from amercury lamp (Spectro-
line SB-100P, Spectronics) equipped with two glass filters (CS0-52, CS7-60,
Ace Glass) so that the wavelength was restricted to 365 ± 15 nm. Periodically,
20 ml aliquots were removed and analyzed by HPLC. The time points collected
were as follows: 0, 20, 40, 60, 90, and 120 s. The concentration of BHQ-O-5HT
remaining (measured by external standard) was plotted versus time of photol-
ysis. A simple single exponential decay curve provided the best fit for the data
and was used to extrapolate t90%. The lamp’s I value was measured using
potassium ferrioxalate actinometry (Hatchard and Parker, 1956). Initially,
6 mM potassium ferrioxalate solution (3 ml) was irradiated with the mercury
lamp for 60 s. A portion of this solution (2 ml) was combined with aqueous
buffer (3 ml), 0.1% phenanthroline solution (3 ml), and 2 M KF solution (1 m)
in a 25 ml volumetric flask. Deionized water was added to generate a 25 ml
solution. A blank solution was also prepared using the same method, but the
potassium ferrioxalate used in the blank was not irradiated. Both solutions
rested for 1 hr, and the blank was then used as a baseline against which the
absorbance of the irradiated solution was measured at 510 nm. The following
equation was used to calculate lamp intensity:
I=
V3DD510
1;000ε510V2fFet
;
where V3 is the volume of dilution (25 ml), V2 is the volume of irradiated potas-
sium ferrioxalate solution taken for analysis (2 ml), DD510 is the absorption of
the solution at 510 nm, ε510 is the actinometry extinction coefficient (1.11 3
104 M1 cm1), fFe is the quantum yield for production of ferrous ions from
potassium ferrioxalate at 365 nm, and t represents the time of irradiation.
The DD510 value used for calculations is the average of two measurements
taken before and after irradiation of BHQ-O-5HT. The Qu of BHQ-OPh and
BHQ-N-5HT was measured similarly.
Determination of du
The du values were measured using previously described methods (Davis
et al., 2009; Fedoryak and Dore, 2002; Furuta et al., 1999; Lu et al., 2003;Chemistry & Biology 20, 1536–154Zhu et al., 2006) using fluorescein as an external standard to estimate the
pulse parameters of the laser. A portion of BHQ-O-5HT was dissolved in
KMOPS buffer, and the concentration of the solution was found using UV-
vis absorption in conjunction with Beer’s law. Aliquots (25 ml) of this solution
were placed in a microcuvette (10 3 1 3 1 mm illuminated dimensions)
and irradiated with an fs-pulsed and mode-locked Ti:sapphire laser with
740 nm light at an average power of 300 mW. Three samples were irradiated
for each of the following time periods: 0, 10, 20, 30, and 40 min. The samples
(20 ml aliquots) were analyzed by HPLC as in theQu measurement to determine
the extent of photolysis at each time point. A solution of fluorescein at pH 9.0
was prepared to act as a standard because of its well-characterized du
(daF = 30 GM at 740 nm) and quantum yield (QF2 = 0.9). UV-vis absorption
at 488 nm was used to determine the fluorescein concentration. Aliquots
(25 ml) of fluorescein solution were placed in the microcuvette and irradiated
by the laser in the same apparatus used for the BHQ-O-5HT photolysis.
The fluorescence emission from the solution was measured with a radiometer
(SED033 detector on an IL-1700, International Light) before and after the
BHQ-O-5HT samples were irradiated, and the two values were averaged.
The following equation was used to calculate the du value for BHQ-O-5HT:
du =
NpfQF2daFCF
hFðtÞiCS ;
where Np is the number of product molecules formed per second (determined
by HPLC), f is the collection efficiency of the detector on the radiometer used
to measure the fluorescence of fluorescein passing through the cuvette win-
dow and through a 535/545 nm bandpass filter at a right angle to the laser’s
beam, CF is the concentration of fluorescein, <F(t)> is the time-averaged fluo-
rescent photon flux (photons per second) of fluorescein measured by the radi-
ometer, and CS is the initial concentration of the caged compound. The du
value of BHQ-OPh and BHQ-N-5HT was measured similarly.
Electrophysiological Recordings
DRG Neurons
Dissociated primary sensory neurons were prepared from mouse DRGs as
described previously (Malin et al., 2007), and plated on lysine/laminin-coated
coverslips. For extracellular recordings, the slips with cells were mounted in
a horizontal perfusion chamber (PC-H, Siskiyou) with a chloride-coated silver
reference electrode attached, and then placed on the stage of an upright mi-
croscope (Examiner.Z1, Zeiss). Solutions of 5-HT (100 mM), BHQ-O-5HT
(500 mM), or BHQ-OH (500 mM) in normal Ringer’s solution containing 1%6, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1543
Figure 7. BHQ-O-5HT Disrupts LR
Patterning in X. laevis Embryos
(A) Position of three organs (heart, red arrow;
stomach, yellow arrow; gall bladder, green arrow)
in wild-type tadpoles and tadpoles with LR
patterning defects.
(B and C) Single-cell embryos were soaked (B) or
injected (C) with 5-HT or BHQ-O-5HT, and LR
defects were assessed after uncaging.
(D) Temporal assessment of BHQ-O-5HT uncag-
ing indicates a critical period for the effect of 5-HT
on LR patterning. Treatment with BHQ-OH ruled
out effects of the PPG and the uncaging light
treatment in LR defects.
*p < 0.01 relative to controls, chi-square test.
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Light-Activated SerotoninDMSO were delivered focally to the desired cell by pressure ejection (Picos-
pritzer II, Parker Hannifin) of 1 nl volumes from a fine-tipped glassmicropipette,
the tip of which was placed 100 ± 10 mm from the cell of interest. Flash photol-
ysis was achieved using a Cairn Flash Photolysis System and OptoSource
xenon and mercury/xenon mixed-gas arc light source (Cairn Research) equip-
ped with a 365/10 nm bandpass filter (Chroma) and coupled by a fiber optic
cable to the Examiner.Z1 microscope through the external port of a Colibri
illumination system. Light was focused on the cells of interest using the
microscope optics and water immersion lenses (203, 403, or 633) with UV
transmission properties. Extracellular recordings were made using glass
microelectrodes (15–20 MU impedance) loaded with normal Ringer’s solution
(116 mM NaCl, 2.9 mM KCl, 1.8 mMCaCl2, 5.0 mMHEPES [pH 7.2]) that were
gently affixed to the soma by suction. Electrical activity was recorded using
an Axoclamp 900a amplifier (Axon Instruments). The amplified voltage was
passed through a Hum Bug Noise Eliminator (AutoMate Scientific), band-
pass-filtered from 1 Hz to 0.1 kHz, and digitized at 10 kHz using a Digidata
1440 interface and stored on a PC using pClamp version 10.3 software
(Axon Instruments). For all experiments, the set-up procedure was carried
out in dark room conditions at RT (23C).
Assessment of Toxicity
The DRG neurons in culture were exposed to BHQ-O-5HT (1 mM) followed by
incubation in the dark for 8–12 hr. Viable cell counts were made using trypan
blue, a dye that is excluded from living cells (Freshney, 1987). The percentage
of dead cells was determined by dividing the number of trypan blue-stained
cells by the total number of cells on a 22 3 22 mm coverslip.1544 Chemistry & Biology 20, 1536–1546, December 19, 2013 ª2013 Elsevier Ltd All rights reLarval Zebrafish
Larval zebrafish of the WIK strain were obtained
from animals maintained in the University of
Georgia Zebrafish Facility following standard
procedures (Westerfield, 2007). Embryos and
larvae were staged using standard staging criteria
(Kimmel et al., 1995; Westerfield, 2007). All exper-
iments conformed to the guidelines on the ethical
use of animals. All experimental procedures were
conducted according to National Institutes of
Health guidelines under protocols approved by
the University of Georgia Institutional Animal
Care and Use Committee and were designed to
minimize animal suffering.
Larval zebrafish, 5 dpf, were immobilized by
exposure to alpha bungarotoxin (Trapani and Nic-
olson, 2010) and mounted in 1.2% agarose made
with normal Ringer’s solution in a 35 mm petri
dish. A sharp glass microelectrode (15–20 MU
impedance), loaded with normal Ringer’s solution,
was placed under visual guidance on the ventral
aspect of the trigeminal ganglion, and the chlo-
ride-coated silver reference wire was placed was
placed touching a dorsal region of the tail. Fordrug delivery, a second sharp glass pipette was inserted in the vicinity of the
maxillary nerve. After a 2 min baseline was recorded, 0.5 nl of 5-HT (100 mM),
BHQ-O-5HT (1mM), or BHQ-OH (1mM) dissolved in Ringer’s solution contain-
ing 1% DMSO was pressure injected (Picospritzer II), and the neurological re-
sponses were recorded. Flash photolysis was achieved, and electrical activity
was recorded as described above. As with the DRG experiments, these exper-
iments were carried out under dark room conditions and at RT.
Assessment of Toxicity
The mortality of the zebrafish larvae after injection of BHQ-O-5HT into the tri-
geminal nerve or the optic tectum was used as a measure of the toxicity of
BHQ-O-5HT. Cell death at the injection site was assessed by differential inter-
ference contrast microscopy, acridine orange staining, or both.
In Vivo Assay of LR Patterning in X. laevis Embryos
Animals
Xenopus embryos were collected and fertilized according to standard proto-
cols (Sive et al., 2000) in 0.13 modified Marc’s Ringer (MMR) at pH 7.8
containing 0.1% gentamicin and staged according to Nieuwkoop and Faber
(1967). This study was carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by Tufts University’s
Institutional Animal Care and Use Committee (M2011-70).
Microinjection of Xenopus Embryos
Single-cell embryos were placed in 3% Ficoll in 13 MMR and injected in the
animal pole using standardmethods (50–100ms pulses with borosilicate glassserved
Chemistry & Biology
Light-Activated Serotoninneedles calibrated for a bubble pressure of 50–70 kPa in water). Injections
occurred under a red lamp to prevent spurious uncaging of the molecules
and were otherwise protected from light. For 5-HT, 30 ng was injected; for
BHQ-O-5HT, 50 ng was injected; for BHQ-OH, 40 ng was injected. After injec-
tions, embryos were washed and incubated at 18C in the dark.
Embryo Soaking
Single-cell embryos were placed in 13MMR containing 5-HT (5 mM) or BHQ-
O-5HT (1 mM). Embryos were washed at stage 5 or stage 8 and returned to
0.13 MMR. After treatment, embryos were washed and kept in 0.13 MMR
at 18C in the dark.
Uncaging 5-HT from BHQ-O-5HT
After soaking or injection with BHQ-O-5HT, embryos were placed on a plat-
form and subjected to high-intensity broad-spectrum light from two light sour-
ces: one source was located below the embryos and one source was located
above the embryos. Light treatment progressed for 1 hr, and embryos were
then washed and returned to a dark 18C incubator.
Laterality Assay
At stage 45, Xenopus embryos were analyzed for position of the heart (looping
to the left), stomach (coiling to the left), and gall bladder (positioned on the
right). Heterotaxia was defined as the reversal in position of one or more
organs. Only embryos with normal dorsoanterior patterning were scored.
The percentage with LR patterning defects was calculated as the absolute
number of heterotaxic embryos divided by the total number of scorable em-
bryos. A chi-square test with Pearson correction for increased stringency
was used to compare absolute counts of heterotaxic embryos.
Assessment of Toxicity
The number of embryos and tadpoles that died or that were otherwise mal-
formed (abnormal dorsoanterior patterning, edema, spina bifida, etc.) was
counted for each treatment group. The toxicity rate was calculated as the
absolute number of dead andmalformed embryos divided by the total number
of embryos. A chi-square test with Pearson’s correction for increased strin-
gency was used to compare toxicity rates between treated and untreated
groups.
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